Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
115.61
-0.32 (-0.28%)
Nov 21, 2024, 10:45 AM EST - Market open
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2023. The number of employees decreased by 1,000 or -0.87% compared to the previous year.
Employees
114,000
Change (1Y)
-1,000
Growth (1Y)
-0.87%
Revenue / Employee
$361,553
Profits / Employee
$50,386
Market Cap
200.52B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
AbbVie | 50,000 |
ABT News
- 1 hour ago - MACH Alliance Expands Education Program, Appoints Dylan Valade of Abbott As Head of Education - Business Wire
- 14 days ago - Abbott India posts Q2 profit rise on strong demand, price hikes - Reuters
- 20 days ago - Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win - Investopedia
- 20 days ago - Abbott shares rise after securing first win in premature infant formula trial - Reuters
- 20 days ago - Abbott Labs and Reckitt Benckiser shares surge on court's baby formula ruling - Market Watch
- 20 days ago - Abbott, Reckitt cleared of liability in latest preterm formula case - Reuters
- 21 days ago - Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead - Reuters
- 23 days ago - My Best Dividend Aristocrats For November 2024 - Seeking Alpha